The 2026 DOJ Health Care Fraud Takedown: What South Florida Providers and Targets Need to Know Now

The Justice Department charged 455 people in a single coordinated sweep on June 23, 2026, and 90 of them are doctors, nurse practitioners, and other licensed medical professionals. The announced loss figure is over $6.5 billion. If you bill Medicare, Medicaid, or TRICARE in South Florida, that number is not background noise. It is a description of the enforcement environment you now practice in. The cases came out of 56 federal districts at once, and the Southern District of Florida and Middle District of Florida both carried significant matters in this round.

The 2026 National Health Care Fraud Takedown charged 455 defendants across 56 federal districts. The Southern District of Florida carried a $3.7 billion DME matter and a $27 million allograft seizure. The enforcement environment has changed.

Key Takeaways

• The 2026 National Health Care Fraud Takedown charged 455 defendants, including 90 medical professionals, over more than $6.5 billion in alleged false claims.
• The governing statutes are 18 U.S.C. § 1347 (health care fraud), 18 U.S.C. § 1349 (conspiracy), and 42 U.S.C. § 1320a-7b(b), the Anti-Kickback Statute.
• Prosecutors opened at least one case within five days of a financial-intelligence flag, so the gap between a billing spike and a federal investigation is now measured in days.
• The Southern District of Florida featured a $3.7 billion durable medical equipment matter and a $27 million seizure tied to allograft bust-out clinics.
• The window to influence a health care fraud case is before indictment, which is exactly the window most providers waste.

A Coordinated Sweep, Not a Single Case

The Department announced the 2026 National Health Care Fraud Takedown on June 23, 2026. The release reports charges against 455 defendants across 56 federal districts and 45 states and territories, with 50 state Medicaid Fraud Control Units taking part. The total alleged fraud exceeds $6.5 billion, and the government reported seizing more than $182 million in cash, vehicles, jewelry, and other assets.

This is not one prosecution. It is a calendar event. Each year the Health Care Fraud Unit batches a large set of unrelated indictments and announces them together for maximum effect. The cases this year cluster around a few recurring patterns: amniotic wound allografts billed at extraordinary markups, hospice and behavioral-health billing for services that were never rendered, and opioid diversion through pill-mill operations.

Florida appears in several of them. In the Middle District of Florida, three defendants were charged in a $118 million allograft scheme. In the Southern District of Florida, the government seized over $27 million tied to a set of clinics that billed Medicare for allografts that never reached a patient.

A records request or subpoena is the first visible sign. The investigation started before it arrived.

Data Analytics Now Opens the Case

Read past the dollar figures and the real story is the machinery. The Health Care Fraud Unit's Data Fusion Center, paired with a new Financial Intelligence Review Team, is combining billing data with bank records to flag outliers in close to real time. The Department highlighted a Medicaid matter where prosecutors opened an investigation within five days of a financial-intelligence review and arrested the defendant less than seven months later. CMS is moving the same way, announcing an arrangement to host the Fraud Division's analytics tools inside the CMS Integrated Data Repository.

Here is what that means in practice. The old assumption that a fraud case starts with a disgruntled employee or a competitor's tip is outdated. A spike in a single billing code, an implausible service-hours total, or a payment pattern that does not match the provider's peer group can put a clinic on a list before anyone walks in the door. The government also showcased a follow-and-seize-the-money posture in the Southern District of Florida, freezing payments and seizing accounts early instead of waiting for trial. That changes the defense calculus, because the asset exposure starts before the indictment does.

The government is now flagging billing anomalies through analytics before a witness ever steps forward.

The Statutes and What They Actually Carry

Most of these cases run on a small group of federal statutes.

Health care fraud under 18 U.S.C. § 1347 carries up to ten years per count, and up to twenty if the scheme results in serious bodily injury. Conspiracy under 18 U.S.C. § 1349 lets the government reach everyone connected to the scheme at the same exposure level as the substantive offense, which is how a marketer or a back-office manager ends up facing the same range as the physician. Kickbacks are charged under the Anti-Kickback Statute, 42 U.S.C. § 1320a-7b(b), which makes a payment to induce a referral a felony and does not require proof that the service was medically unnecessary. Opioid cases add 21 U.S.C. § 841, which treats unlawful prescribing as drug distribution.

The number that drives a federal health care fraud sentence is loss. Under the Sentencing Guidelines, the alleged loss amount, not the actual harm, sets the base exposure, and intended loss can be charged even where the government never paid the claim. Layer in enhancements for the number of victims, the role in the offense, and any abuse of a position of trust, and a case that looked like a billing dispute becomes guideline territory that starts in years.

There is almost always a parallel civil track. The False Claims Act, 31 U.S.C. § 3729, lets the government recover treble damages and per-claim penalties, and the takedown itself reported tens of millions in civil settlements running alongside the criminal charges. Money laundering counts under 18 U.S.C. § 1956 often follow the proceeds.

The Early Errors That Cost the Most

The damage in these cases is usually self-inflicted in the first few weeks.

Talking to agents without counsel. A friendly visit from HHS-OIG or the FBI is not a chance to clear things up. It is an interview, and the answers become evidence.

Producing documents without a strategy or a litigation hold. Handing over records you have not reviewed, or worse, altering them, turns a billing case into an obstruction case.

Assuming the matter is not serious because no one has been charged. The pre-indictment phase is when the government decides who to charge and for how much. Silence from the prosecutor is not safety.

Waiting for the indictment to hire a lawyer. By then the charging decision is made, assets may already be frozen, and the leverage that existed at the target-letter stage is gone.

By the time a federal indictment arrives, the charging decision is already made. The pre-indictment window is where the outcome is shaped.

Where These Cases Are Actually Won

The work that matters happens before the grand jury returns anything. When a client comes in at the subpoena or target-letter stage, there is room to shape the outcome: present exculpatory billing context, challenge the government's loss theory before it hardens into an indictment number, and where appropriate, open a controlled dialogue with the prosecutor rather than waiting to be charged. Early federal investigation defense can mean the difference between a target who gets indicted and a witness who does not, or between a fraud count and a civil resolution.

The cooperation-versus-litigation decision is real and it is not one-size-fits-all. For some clients, an early and credible proffer protects them. For others, it hands the government its case. That decision should be made with a federal criminal defense attorney who has sat on both sides of it in federal court, not under pressure in an agent's car.

If charges do proceed, the same early work feeds directly into sentencing. A documented challenge to the loss amount, a clear picture of the client's actual role, and mitigation built from day one all move the guideline math.

The Clock Is Already Running

The defining feature of this year's takedown is speed. The government is identifying targets through analytics, moving on assets early, and compressing the timeline from flag to arrest. For a provider in South Florida, the safe assumption is that a billing anomaly is already visible to someone, whether or not a subpoena has arrived.

Charging decisions are still fluid in that early window. They do not stay fluid. The providers who come out of these investigations best are the ones who treat the first sign of scrutiny as the start of a defense, not a paperwork problem.

Common Questions

Facing a Federal Healthcare Fraud Investigation in Florida?

If you are a physician, nurse practitioner, clinic owner, marketer, DME supplier, or pharmacy operator and you have received a subpoena, a target letter, a records request, or an unexplained payment freeze, the time to act is before a charging decision is made. AMC Defense Law represents clients in federal health care fraud investigations and prosecutions in the Southern District of Florida and nationwide. Consultations are confidential.

Aaron M. Cohen represents physicians, clinic owners, DME suppliers, and pharmacy operators in federal healthcare fraud investigations in the Southern District of Florida and nationwide.

This article is for informational purposes only and does not constitute legal advice. Reading this article does not create an attorney-client relationship. If you are under investigation or believe you may be a target of a federal health care fraud investigation, consult a qualified federal criminal defense attorney immediately.